Nanophase Technologies CORP Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Solesence, Inc. Reports Significant Internal Share Transfer Among Controlling Entities, Whitmore Group Maintains 71% Stake
An amendment to a Schedule 13D filing reveals an internal transfer of 6.689 million shares of Solesence, Inc. common stock between entities controlled by Bradford T. Whitmore, who collectively maintain a 71% beneficial ownership.